Gene therapy in peripheral nerve reconstruction approaches.

Area of Science:

• Regenerative Medicine
• Neuroscience
• Gene Therapy

Background:

• Neurosurgical reconstruction alone may not fully restore function after severe peripheral nerve injuries.
• Axonal regeneration and neuronal survival are critical for functional recovery but are often impaired.
• Gene therapy presents a novel strategy to address these limitations in peripheral nerve repair.

Purpose of the Study:

• To review current methods and future perspectives for gene therapy in promoting functional recovery of peripheral nerves.
• To explore the potential of gene therapy in enhancing axonal regeneration and neuronal survival post-injury.
• To evaluate the clinical relevance of in vivo and ex vivo gene therapy approaches for peripheral nerve reconstruction.

Main Methods:

• Review of experimental in vivo gene therapy, typically involving direct injection of cDNA vectors into injured nerves.
• Review of experimental ex vivo gene therapy, utilizing genetically modified autologous cells for tissue-engineered nerve transplants.
• Discussion of various vector origins and their suitability for peripheral nerve gene therapy applications.

Main Results:

• Gene therapy facilitates the delivery of regeneration-promoting molecules and survival proteins to injured sensory and motor neurons.
• Both in vivo and ex vivo approaches have demonstrated potential in experimental settings.
• Different vector strategies show varying efficiencies, risks, and clinical applicability.

Conclusions:

• Gene therapy holds significant promise for long-term, site-specific delivery of neurotrophic factors to enhance peripheral nerve repair.
• Further research into vector efficiency, safety, and clinical translation is warranted for successful application.
• This therapeutic approach could significantly improve functional outcomes for patients with severe peripheral nerve injuries.